Editorial
doi: 10.1097/gme.0b013e3181bc1c84.
Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators
- PMID: 19779314
- DOI: 10.1097/gme.0b013e3181bc1c84
Item in Clipboard
Editorial
Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators
Menopause.
2009 Nov-Dec.
No abstract available
Comment on
-
Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.Menopause. 2009 Nov-Dec;16(6):1109-15. doi: 10.1097/gme.0b013e3181a818db. Menopause. 2009. PMID: 19543129 Clinical Trial.
-
Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.Menopause. 2009 Nov-Dec;16(6):1102-8. doi: 10.1097/gme.0b013e3181a816be. Menopause. 2009. PMID: 19546825 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
